Continuous infusions of Δ⁴-androstenedione-7-³H and testosterone-7-³H have been used to demonstrate that these androgens are converted to estrone and 17β-estradiol, and contribute to the circulating blood levels of these estrogens in normal males and females. The conversion ratio (ratio of concentrations of radioactivity of free product steroid [χ^-PRO] and free precursor steroid [χ^-PRE], both corrected for recoveries, after an infusion of radioactive precursor steroid) for androstenedione (precursor) to estrone (product) is 0.013 in males and 0.007 in females, and the conversion ratio for testosterone (precursor) to estradiol (product) is 0.0018 in males and 0.005 in females. The transfer constant, [ρ]_BB^AE1, for androstenedione conversion to estrone ([ρ]_BB^AE1 = per cent of infused androstenedione, precursor, converted to estrone, product, when infusion and measurement are both in blood) is 1.35% in males and 0.74% in females, and the transfer constant, [ρ]_BB^TE2, for testosterone conversion to estradiol is 0.39% in males and 0.15% in females.

Whether measured as conversion ratio or transfer constant, the peripheral aromatization of androstenedione takes place to a greater degree than that of testosterone, and, for the respective androgens, both the conversion ratio and [ρ]_BB value are greater in males than females.

For the androgen interconversions, [ρ]_BB^AT is 4.5% in males and 2.2% in females; [ρ]_BB^TA is 8.2% in males and 12.0% in females.

Studies on the distribution coefficients (effective concentration in red cells/plasma) for precursor radioactivity were also made. In both males and females the distribution coefficient for androstenedione is 0.16-0.17 while that of testosterone is 0.01-0.03.